We do not know whether women who developed GDM in our study had low IGFBP1 levels before pregnancy, thus pre-pregnancy assessment of IGFBP1 should be considered in future studies of pre-conception interventions aiming to optimize metabolic outcomes in pregnancy. The gene discussed is IGFBP1; the disease is gestational diabetes.